Vattenfall, Novozymes and Novo Nordisk sign a long term Power Purchase Agreement from Denmark’s largest offshore wind park, Kriegers Flak
Production of insulin and enzymes is to be based on renewable energy from Denmark’s largest offshore wind farm, Kriegers Flak in the Baltic Sea. This is the result of a new long-term deal between global healthcare company Novo Nordisk, bio innovator Novozymes and the energy company Vattenfall.Novo Nordisk and Novozymes will source their power consumption from Vattenfall and its offshore wind farm Kriegers Flak, which is being developed in the Baltic Sea. The deal will cover approximately a fifth of the farm’s production.
Kriegers Flak is scheduled to be in full operation by the end of
